Manulife (Manufacturers Life Insurance)’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NVIV Stock Details NVIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1	Closed	-$111K	–	4527
2017 Q1	$111K	Hold	1	–	–	﹤0.01%	3151
2016 Q4	$108K	Hold	1	–	–	﹤0.01%	3191
2016 Q3	$157K	Hold	1	–	–	﹤0.01%	2956
2016 Q2	$136K	Hold	1	–	–	﹤0.01%	3033
2016 Q1	$131K	Hold	1	–	–	﹤0.01%	2902
2015 Q4	$131	Hold	1	–	–	﹤0.01%	2963
2015 Q3	$150	Hold	1	–	–	﹤0.01%	2889
2015 Q2	$276	Buy	+1	New	+$264K	﹤0.01%	2585

Other funds holding NVIV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ICM

IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NVIV Position: Q2 2017 in Review

Manulife (Manufacturers Life Insurance) sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q2 2017, closing a stake of 1 share — an estimated $111K sold.

Manulife (Manufacturers Life Insurance) first reported a position in NVIV in Q2 2015 and held it in 8 quarters. The position peaked at $157K in Q3 2016. 37 funds tracked by Wall St. Rank hold NVIV as of Q2 2017.

Manulife (Manufacturers Life Insurance) reported no remaining InVivo Therapeutics Holdings Corp position as of Q2 2017 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 1 InVivo Therapeutics Holdings Corp share in Q2 2017, an estimated $111K.
Manulife (Manufacturers Life Insurance) first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and held it in 8 quarters.
Manulife (Manufacturers Life Insurance)'s InVivo Therapeutics Holdings Corp position peaked at $157K in Q3 2016.
37 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q2 2017.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2017, filed 15 Aug 2017.